RP9 Activators
RP9 Activators are a diverse set of chemical compounds that enhance the functional activity of RP9 through varied signaling mechanisms. Forskolin, Isoproterenol, Dibutyryl-cAMP, and Rolipram induce elevations in intracellular cAMP levels, which lead to the activation of protein kinase A (PKA). The activation of PKA is known to result in phosphorylation events that could directly enhance the activity of RP9 or may influence the proteins with which RP9 interacts. Similarly, 8-Bromo-cAMP functions as a synthetic analog of cAMP, activating PKA and potentially facilitating RP9 phosphorylation and subsequent activation. On another front, ionomycin and A23187 act as calcium ionophores, increasing intracellular calcium concentrations, which could activate calcium/calmodulin-dependent protein kinases (CaMKs). These kinases may then phosphorylate RP9 or its associated proteins, enhancing RP9's functional activity within the cell.
In addition to these cAMP- and calcium-related activators, Phorbol 12-myristate 13-acetate (PMA) and Histamine employ PKC, which may phosphorylate proteins affecting RP9's activity or localization. Anisomycin, by activating MAPK pathways, andStaurosporine, through its inhibitory effects on protein kinases, could lead to the paradoxical activation of pathways that enhance the function of RP9 by altering the phosphorylation status of associated proteins. Chelerythrine, while generally understood as a PKC inhibitor, may invoke feedback mechanisms that activate alternative signaling pathways, possibly resulting in the stabilization of RP9 in its active conformation. Collectively, these RP9 Activators work through a synergy of signaling pathways involving cAMP, calcium, and kinase modulation, leading to the enhancement of RP9's cellular functions without directly increasing its expression levels.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels in cells. Elevated cAMP may enhance RP9 function by cAMP-dependent protein kinase (PKA) activation, which could phosphorylate substrates that interact with RP9, resulting in its functional enhancement. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can lead to phosphorylation events that may enhance the functional activity of RP9 by modulating its interaction with other proteins or its localization within the cell. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially enhancing RP9 function by activating calcium/calmodulin-dependent protein kinases (CaMKs), which might phosphorylate RP9 or associated proteins, thereby increasing RP9 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate substrates that modulate RP9 activity or facilitate its recruitment to specific cellular compartments where it is active. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels via G-protein coupled receptor signaling, potentially enhancing RP9 activity through PKA-mediated phosphorylation pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog resistant to degradation, which activates PKA. Persistent PKA activation by db-cAMP may enhance RP9 activity by phosphorylating regulatory proteins that affect RP9 function. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium concentration, potentially enhancing RP9 function by activating CaMKs or other calcium-sensitive signaling proteins that may interact with RP9. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can activate phospholipase C via H1 receptor signaling, leading to PKC activation. PKC may enhance RP9 activity by phosphorylating substrates that interact with RP9. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels. Higher cAMP may enhance RP9 activity via PKA-mediated signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates MAPK pathways, potentially leading to phosphorylation events that enhance RP9 activity by modulating its interaction with signaling proteins. | ||||||